<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Public Health</journal-id>
<journal-title>Frontiers in Public Health</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Public Health</abbrev-journal-title>
<issn pub-type="epub">2296-2565</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fpubh.2024.1377408</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Public Health</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Association of two novel systemic inflammatory biomarkers and frailty based on NHANES 2007&#x2013;2018</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Zhang</surname> <given-names>Huiling</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2612753/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Liu</surname> <given-names>Xinyu</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author"><name><surname>Wang</surname> <given-names>Xiaoling</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes"><name><surname>Jiang</surname> <given-names>Ya</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2642044/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>The First Clinical Medical College, Shandong University of Traditional Chinese Medicine</institution>, <addr-line>Jinan</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Cardiology, Linyi Traditional Chinese Medicine Hospital</institution>, <addr-line>Linyi</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0002">
<p>Edited by: Emiliana Giacomello, University of Trieste, Italy</p>
</fn>
<fn fn-type="edited-by" id="fn0003">
<p>Reviewed by: Tuba Duman, Abant Izzet Baysal University, T&#x00FC;rkiye</p>
<p>Haider Abdul-Lateef Mousa, University of Basrah, Iraq</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Ya Jiang, <email>Jiangya2024@163.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>08</day>
<month>04</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>12</volume>
<elocation-id>1377408</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024 Zhang, Liu, Wang and Jiang.</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Zhang, Liu, Wang and Jiang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec id="sec1">
<title>Background</title>
<p>Frailty is a significant concern in the field of public health. However, currently, there is a lack of widely recognized and reliable biological markers for frailty. This study aims to investigate the association between systemic inflammatory biomarkers and frailty in the older adult population in the United States.</p>
</sec>
<sec id="sec2">
<title>Methods</title>
<p>This study employed data from the National Health and Nutrition Examination Survey (NHANES) spanning 2007 to 2018 and conducted a rigorous cross-sectional analysis. We constructed weighted logistic regression models to explore the correlation between the Systemic Immune-Inflammation Index (SII), Systemic Inflammatory Response Index (SIRI), and frailty in the population aged 40 to 80&#x2009;years. Using restricted cubic spline (RCS), we successfully visualized the relationship between SII, SIRI, and frailty. Finally, we presented stratified analyses and interaction tests of covariates in a forest plot.</p>
</sec>
<sec id="sec3">
<title>Results</title>
<p>This study involved 11,234 participants, 45.95% male and 54.05% female, with an average age of 64.75&#x2009;&#x00B1;&#x2009;0.13&#x2009;years. After adjusting for relevant covariates, the weighted logistic regression model indicated an odds ratio (OR) and 95% confidence interval(CI) for the correlation between frailty and the natural logarithm (ln) transformed lnSII and lnSIRI as 1.38 (1.24&#x2013;1.54) and 1.69 (1.53&#x2013;1.88), respectively. Subsequently, we assessed different levels of lnSII and lnSIRI, finding consistent results. In the lnSII group model, the likelihood of frailty significantly increased in the fourth quartile (OR&#x2009;=&#x2009;1.82, 95% CI: 1.55&#x2013;2.12) compared to the second quartile. In the lnSIRI group model, the likelihood of frailty significantly increased in the third quartile (OR&#x2009;=&#x2009;1.30, 95% CI: 1.10&#x2013;1.53) and fourth quartile (OR&#x2009;=&#x2009;2.29, 95% CI: 1.95&#x2013;2.70) compared to the second quartile. The interaction results indicate that age and income-to-poverty ratio influence the association between lnSIRI and frailty. RCS demonstrated a nonlinear relationship between lnSII, lnSIRI, and frailty.</p>
</sec>
<sec id="sec4">
<title>Conclusion</title>
<p>The results of this cross-sectional study indicate a positive correlation between systemic inflammatory biomarkers (SII, SIRI) and frailty.</p>
</sec>
</abstract>
<kwd-group>
<kwd>frailty</kwd>
<kwd>SIRI</kwd>
<kwd>SII</kwd>
<kwd>systemic inflammatory biomarkers</kwd>
<kwd>NHANES</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="4"/>
<equation-count count="0"/>
<ref-count count="47"/>
<page-count count="10"/>
<word-count count="5498"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Aging and Public Health</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec5"><label>1</label>
<title>Introduction</title>
<p>Frailty, as a multifactorial syndrome, manifests a trend of increasing physiological system impairments with age and may significantly reduce survival rates at any age (<xref ref-type="bibr" rid="ref1">1</xref>). A key characteristic of frailty is the gradual weakening of physiological systems and an exceptional sensitivity to various stresses and pressures in daily life (<xref ref-type="bibr" rid="ref2">2</xref>). Frailty may trigger and exacerbate other health issues; therefore, prevention and slowing the progression of frailty are crucial. Frailty is determined by multiple indicators, including the Edmonton Frail Scale (<xref ref-type="bibr" rid="ref3">3</xref>), the Geriatric Nutritional Risk Index (<xref ref-type="bibr" rid="ref4">4</xref>), the Frailty Index (FI) (<xref ref-type="bibr" rid="ref5">5</xref>), and the Fried phenotype, among others. Among these, FI performs well in distinguishing frailty states (<xref ref-type="bibr" rid="ref6">6</xref>). An increased burden of inflammation also characterizes frailty (<xref ref-type="bibr" rid="ref7">7</xref>). Systemic Immune-Inflammation Index (SII) (<xref ref-type="bibr" rid="ref8">8</xref>) and Systemic Inflammatory Response Index (SIRI) (<xref ref-type="bibr" rid="ref9">9</xref>) are novel markers linked with inflammatory conditions.</p>
<p>Blood inflammation markers are cost-effective and easily accessible biomarkers. Serving as indicators of both local immune response and systemic inflammation, SII is a robust and stable metric, integrating three types of inflammatory cells (lymphocytes, neutrophils, and platelets) (<xref ref-type="bibr" rid="ref10 ref11 ref12">10&#x2013;12</xref>). Numerous studies have indicated that the SII can predict the prognosis of patients with various cancers, acute ischemic stroke, heart failure, and acute kidney injury (<xref ref-type="bibr" rid="ref13">13</xref>). SIRI, composed of lymphocytes, monocytes, and neutrophils, represents a more comprehensive indicator of chronic inflammation (<xref ref-type="bibr" rid="ref14">14</xref>). Previous research suggests that SIRI is a potential marker for early diagnosis and prognosis monitoring in conditions such as stroke, inflammatory diseases, and cancer (<xref ref-type="bibr" rid="ref15">15</xref>). Additionally, previous research has found an association between C-reactive protein and interleukin-6 with frailty (<xref ref-type="bibr" rid="ref16">16</xref>).</p>
<p>Some studies have indicated an association between systemic inflammatory biomarkers and the risk of frailty (<xref ref-type="bibr" rid="ref17">17</xref>). However, current research has limitations, including small sample sizes and a single definition of frailty. The universality and reliability of this association require validation and further confirmation through larger-scale studies. In this study, we conducted a rigorous analysis using a large sample from the National Health and Nutrition Examination Survey (NHANES) data spanning 2007 to 2018 to explore the correlation between SIRI, SII, and frailty. This research aims to gain deeper insights into the impact of systemic inflammatory biomarkers on frailty, ultimately providing more effective healthcare recommendations for individuals.</p>
</sec>
<sec sec-type="methods" id="sec6"><label>2</label>
<title>Methods</title>
<sec id="sec7"><label>2.1</label>
<title>Study population</title>
<p>These data are available from the NHANES database (<xref ref-type="bibr" rid="ref18">18</xref>). This database comprises a series of nationally representative surveys designed to assess U.S. citizens&#x2019; health and nutritional status (<xref ref-type="bibr" rid="ref19">19</xref>). The database has received approval from the National Center for Health Statistics Ethics Review Board, and the participants have obtained written consent (<xref ref-type="bibr" rid="ref20">20</xref>). We conducted data analysis on the most recent six NHANES survey cycles (2007&#x2013;2018), encompassing 15,155 participants, followed by a series of exclusions.<list list-type="order">
<list-item>
<p>Exclusion of participants with less than 80% of FI features (&#x003C; 40 items) (n&#x2009;=&#x2009;244);</p>
</list-item>
<list-item>
<p>Exclusion of participants with age&#x2009;&#x003C;&#x2009;40&#x2009;years (<italic>n</italic>&#x2009;=&#x2009;1,396);</p>
</list-item>
<list-item>
<p>Exclusion of individuals with insufficient baseline information (gender, race, education, marital status, income poverty ratio) (<italic>n</italic>&#x2009;=&#x2009;1,402);</p>
</list-item>
<list-item>
<p>Exclusion of individuals with missing covariates (alcohol consumption, smoking) (<italic>n</italic>&#x2009;=&#x2009;500);</p>
</list-item>
<list-item>
<p>Exclusion of individuals with missing values for SII and SIRI (<italic>n</italic>&#x2009;=&#x2009;379).</p>
</list-item>
</list></p>
<p>Ultimately, it includes 11,234 participants, as depicted in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p>
<fig position="float" id="fig1"><label>Figure 1</label>
<caption>
<p>Flow chart of sample selection.</p>
</caption>
<graphic xlink:href="fpubh-12-1377408-g001.tif"/>
</fig>
</sec>
<sec id="sec8"><label>2.2</label>
<title>Frailty</title>
<p>Following the approach proposed by Hakeem et al., we utilized the FI to assess the degree of frailty. This index comprises 49 variables spanning multiple systems, covering aspects such as cognition, dependency, depressive symptoms, comorbidities, general health status, hospital utilization, physical performance, body measurements, and laboratory test values (<xref ref-type="bibr" rid="ref21 ref22 ref23">21&#x2013;23</xref>). The eligibility survey required a completion rate of at least 80% (approximately 40 items) for the 49 frailty items. We assigned scores ranging from 0 to 1 based on the severity of defects (see <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>)<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref>. The FI is the sum of defect scores obtained by participants divided by the potential total defect score. With a critical threshold for the FI set at 0.21, values greater than or equal to 0.21 are defined as frail, while values less than 0.21 are non-frail (<xref ref-type="bibr" rid="ref24">24</xref>).</p>
</sec>
<sec id="sec9"><label>2.3</label>
<title>Systemic inflammatory biomarkers</title>
<p>An automated hematology analyzer will evaluate lymphocyte, neutrophil, platelet, and monocyte counts expressed as &#x00D7;10<sup>3</sup> cells/&#x03BC;L (<xref ref-type="bibr" rid="ref25">25</xref>). We calculated two systemic inflammatory markers based on peripheral blood cell counts: SII and SIRI. The calculation formula for SII is platelet count &#x00D7; neutrophil/lymphocyte count (<xref ref-type="bibr" rid="ref26">26</xref>). The calculation formula for SIRI is neutrophil count &#x00D7; monocyte count/lymphocyte count (<xref ref-type="bibr" rid="ref27">27</xref>).</p>
</sec>
<sec id="sec10"><label>2.4</label>
<title>Covariates</title>
<p>Correlation logic and previously published literature guided the selection of covariates. We collected statistical data on basic participant information, including age, gender, race, education level, marital status, income poverty ratio, and statistics on alcohol and smoking habits. Specifically, age into two groups: &#x003C;40&#x2009;years and&#x2009;&#x2265;&#x2009;40&#x2009;years; gender into two groups: male and female; race into five groups: Mexican American, other Hispanic, non-Hispanic White, non-Hispanic Black, and other races, including multiple races; education level into three groups: less than high school, high school or general education diploma, and more than high school (<xref ref-type="bibr" rid="ref28">28</xref>); marital status into three groups: married/living with a partner, never married, and separated/divorced/widowed (<xref ref-type="bibr" rid="ref29">29</xref>); The income poverty ratio is categorized into three groups: low (&#x2264;1.3), moderate (1.3&#x2013;3.5), and high (&#x003E;3.5). It is calculated by dividing the family&#x2019;s (or individual&#x2019;s) income by the poverty threshold specific to the survey year. A lower income poverty ratio indicates lower income for the family (or individual). Based on the response to the question, &#x201C;Have you smoked at least 100 cigarettes in your entire life?&#x201D; participants were categorized as smokers or non-smokers. Based on responses to questions about drinking at least 12 alcoholic beverages in the past year and ever drinking any alcoholic beverage, participants were drinkers or non-drinkers (<xref ref-type="bibr" rid="ref30">30</xref>).</p>
</sec>
<sec id="sec11"><label>2.5</label>
<title>Statistical analysis</title>
<p>In this study, statistical analyses followed the recommendations of the Centers for Disease Control and Prevention guidelines. We were considering the complexity and multi-stage sampling design of NHANES data collection and sampling weights in the statistical analysis. We compared the baseline characteristics between frail and non-frail individuals, as well as the baseline characteristics of different quartiles of the natural logarithm (ln) transformed SII (lnSII) and SIRI (lnSIRI). For normally distributed quantitative data, we used the t-test, and for qualitative data, we employed the &#x03C7;<sup>2</sup> test. Descriptive statistics presented continuous variables using mean&#x2009;&#x00B1;&#x2009;standard deviation and categorical variables using percentages with 95% confidence intervals. Subsequently, weighted logistic regression models estimate the relationships between lnSII, lnSIRI, and frailty in three different models. Model 1 was a basic unadjusted model; Model 2 adjusted for age, gender, race, income poverty ratio, education level, and marital status; Model 3 included all variables in Model 2, plus smoking and drinking status. Furthermore, restricted cubic splines (RCS) were employed to detect potential non-linear relationships between lnSII, lnSIRI, and frailty. We performed Subgroup and interaction analyses for age, gender, education, marital status, income and poverty ratio, smoking, and drinking. All analyses use R software (V.4.3.2), Stata software (version 17), and SPSS software (version 27). Statistically significant: A significance level of <italic>p</italic>&#x2009;&#x003C;&#x2009;0.05 was considered.</p>
</sec>
</sec>
<sec sec-type="results" id="sec12"><label>3</label>
<title>Results</title>
<sec id="sec13"><label>3.1</label>
<title>The baseline features of the participants</title>
<p>11,234 participants were included, with males comprising 45.95% and females 54.05%. Clinical characteristics of participants, stratified by frailty status, are presented in <xref ref-type="table" rid="tab1">Table 1</xref>. The proportions of lnSII four quartiles among frail patients were 21.24, 21.80, 23.7, and 33.26%, respectively, while lnSIRI four quartiles were 20.08, 21.25, 25.01, and 33.67%, respectively. Frailty showed statistical significance (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05) concerning age, gender, race, education level, marital status, income poverty ratio, alcohol consumption, smoking status, lnSIRI, and lnSII. Compared to non-frail individuals, frail patients are often female, have lower educational levels, lower income poverty ratio, are less likely to be married or living with a partner, and are more likely to smoke. Additionally, they tend to have higher levels of lnSII and lnSIRI. The mean age of frail patients is 64.29&#x2009;&#x00B1;&#x2009;0.22&#x2009;years.</p>
<table-wrap position="float" id="tab1"><label>Table 1</label>
<caption>
<p>Baseline characteristics of weighted sample by frailty and non-frailty groups.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="top">Total</th>
<th align="center" valign="top">Non-frailty</th>
<th align="center" valign="top">frailty</th>
<th align="center" valign="top"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Sample size</td>
<td align="center" valign="middle">1,1,234</td>
<td align="center" valign="middle">6,690</td>
<td align="center" valign="middle">4,544</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Age, Mean</td>
<td align="center" valign="middle">64.75&#x2009;&#x00B1;&#x2009;0.13</td>
<td align="center" valign="middle">65.02&#x2009;&#x00B1;&#x2009;0.16</td>
<td align="center" valign="middle">64.29&#x2009;&#x00B1;&#x2009;0.22</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">lnSII, Mean</td>
<td align="center" valign="middle">6.18&#x2009;&#x00B1;&#x2009;0.01</td>
<td align="center" valign="middle">6.14&#x2009;&#x00B1;&#x2009;0.01</td>
<td align="center" valign="middle">6.23&#x2009;&#x00B1;&#x2009;0.01</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">lnSIRI, Mean</td>
<td align="center" valign="middle">0.17&#x2009;&#x00B1;&#x2009;0.01</td>
<td align="center" valign="middle">0.12&#x2009;&#x00B1;&#x2009;0.01</td>
<td align="center" valign="middle">0.25&#x2009;&#x00B1;&#x2009;0.01</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">Gender</td>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">Men</td>
<td align="center" valign="middle">45.95(44.63&#x2013;47.27)</td>
<td align="center" valign="middle">49.78(48.05&#x2013;51.51)</td>
<td align="center" valign="middle">39.27(37.32&#x2013;41.26)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Women</td>
<td align="center" valign="middle">54.05(52.73&#x2013;55.37)</td>
<td align="center" valign="middle">50.22(48.49&#x2013;51.95)</td>
<td align="center" valign="middle">60.73(58.74&#x2013;62.68)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Race</td>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">Mexican American</td>
<td align="center" valign="middle">4.41(4.13&#x2013;4.71)</td>
<td align="center" valign="middle">3.96(3.63&#x2013;4.31)</td>
<td align="center" valign="middle">5.19(4.69&#x2013;5.74)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Hispanic</td>
<td align="center" valign="middle">3.86(3.59&#x2013;4.14)</td>
<td align="center" valign="middle">3.47(3.17&#x2013;3.80)</td>
<td align="center" valign="middle">4.53(4.03&#x2013;5.09)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Non-Hispanic White</td>
<td align="center" valign="middle">76.87(76.02&#x2013;77.69)</td>
<td align="center" valign="middle">79.60(78.61&#x2013;80.56)</td>
<td align="center" valign="middle">72.10(70.58&#x2013;73.58)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Non-Hispanic Black</td>
<td align="center" valign="middle">9.15(8.72&#x2013;9.60)</td>
<td align="center" valign="middle">7.51(7.04&#x2013;8.01)</td>
<td align="center" valign="middle">12.00(11.18&#x2013;12.87)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Other race</td>
<td align="center" valign="middle">5.72(5.22&#x2013;6.27)</td>
<td align="center" valign="middle">5.46(4.90&#x2013;6.09)</td>
<td align="center" valign="middle">6.17(5.24&#x2013;7.26)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Marital</td>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">Married/living with a partner</td>
<td align="center" valign="middle">62.53(61.29&#x2013;63.76)</td>
<td align="center" valign="middle">66.92(65.34&#x2013;68.47)</td>
<td align="center" valign="middle">54.88(52.89&#x2013;56.85)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Never married</td>
<td align="center" valign="middle">6.33(5.74&#x2013;6.98)</td>
<td align="center" valign="middle">5.66(4.95&#x2013;6.47)</td>
<td align="center" valign="middle">7.50(6.51&#x2013;8.62)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Separated/divorced/widowed</td>
<td align="center" valign="middle">31.14(29.99&#x2013;32.31)</td>
<td align="center" valign="middle">27.41(25.98&#x2013;28.90)</td>
<td align="center" valign="middle">37.62(35.76&#x2013;39.52)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Education</td>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">&#x003C;&#x2009;High school</td>
<td align="center" valign="middle">17.66(16.86&#x2013;18.49)</td>
<td align="center" valign="middle">13.64(12.74&#x2013;14.60)</td>
<td align="center" valign="middle">24.67(23.19&#x2013;26.21)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">High school</td>
<td align="center" valign="middle">25.38(24.25&#x2013;26.55)</td>
<td align="center" valign="middle">23.54(22.11&#x2013;25.03)</td>
<td align="center" valign="middle">28.59(26.77&#x2013;30.49)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">&#x003E;&#x2009;High school</td>
<td align="center" valign="middle">56.96(55.67&#x2013;58.23)</td>
<td align="center" valign="middle">62.82(61.20&#x2013;64.42)</td>
<td align="center" valign="middle">46.73(44.71&#x2013;48.77)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Income poverty ratio</td>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">&#x003C;&#x2009;1.3</td>
<td align="center" valign="middle">22.10(21.20&#x2013;23.03)</td>
<td align="center" valign="middle">15.20(14.26&#x2013;16.19)</td>
<td align="center" valign="middle">34.14(32.39&#x2013;35.93)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">(1.3&#x2013;3.5)</td>
<td align="center" valign="middle">38.41(37.15&#x2013;39.68)</td>
<td align="center" valign="middle">36.36(34.76&#x2013;37.99)</td>
<td align="center" valign="middle">41.97(39.99&#x2013;43.97)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">&#x2265;3.5</td>
<td align="center" valign="middle">39.49(38.13&#x2013;40.86)</td>
<td align="center" valign="middle">48.44(46.70&#x2013;50.19)</td>
<td align="center" valign="middle">23.89(21.98&#x2013;25.91)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Smoke</td>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">Yes</td>
<td align="center" valign="middle">52.84(51.52&#x2013;54.16)</td>
<td align="center" valign="middle">48.72(46.99&#x2013;50.44)</td>
<td align="center" valign="middle">60.03(58.05&#x2013;61.99)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">No</td>
<td align="center" valign="middle">47.16(45.84&#x2013;48.48)</td>
<td align="center" valign="middle">51.28(49.56&#x2013;53.01)</td>
<td align="center" valign="middle">39.97(38.01&#x2013;41.95)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Alcohol use</td>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">Yes</td>
<td align="center" valign="middle">75.92(74.86&#x2013;76.94)</td>
<td align="center" valign="middle">77.19(75.83&#x2013;78.49)</td>
<td align="center" valign="middle">73.69(72.02&#x2013;75.30)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">No</td>
<td align="center" valign="middle">24.08(23.06&#x2013;25.14)</td>
<td align="center" valign="middle">22.81(21.51&#x2013;24.17)</td>
<td align="center" valign="middle">26.31(24.70&#x2013;27.98)</td>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
<p>Among the 11,234 participants, 63.54% were non-frail, and 36.46% as frail. Stratifying by different levels of lnSIRI, significant differences in frailty, age, gender, race, education, marital status, income and poverty ratio, alcohol consumption, and smoking status were observed (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05). The proportions of the four categories of frailty were 34.96, 29.48, 34.43, and 46.69%, as illustrated in <xref ref-type="table" rid="tab2">Table 2</xref>.</p>
<table-wrap position="float" id="tab2"><label>Table 2</label>
<caption>
<p>Baseline characteristics of the study population stratified by quartiles of lnSIRI value.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="top">lnSIRI total</th>
<th align="center" valign="top">Q1(&#x2265; &#x2212;&#x2009;0.29)</th>
<th align="center" valign="top">Q2(&#x2212;0.29 to 0.11)</th>
<th align="center" valign="top">Q3(0.11&#x2013;0.52)</th>
<th align="center" valign="top">Q4(&#x2265;0.52)</th>
<th align="center" valign="top"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Sample size</td>
<td align="center" valign="middle">11,234</td>
<td align="center" valign="middle">2,808</td>
<td align="center" valign="middle">2,808</td>
<td align="center" valign="middle">2,808</td>
<td align="center" valign="middle">2,810</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Year</td>
<td align="center" valign="middle">64.75&#x2009;&#x00B1;&#x2009;0.13</td>
<td align="center" valign="middle">62.73&#x2009;&#x00B1;&#x2009;0.25</td>
<td align="center" valign="middle">63.94&#x2009;&#x00B1;&#x2009;0.26</td>
<td align="center" valign="middle">65.15&#x2009;&#x00B1;&#x2009;0.26</td>
<td align="center" valign="middle">66.77&#x2009;&#x00B1;&#x2009;0.26</td>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">Gender</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">Male</td>
<td align="center" valign="middle">45.95(44.63&#x2013;47.27)</td>
<td align="center" valign="middle">32.51(30.00&#x2013;35.13)</td>
<td align="center" valign="middle">41.42(38.78&#x2013;44.11)</td>
<td align="center" valign="middle">49.41(46.79&#x2013;52.02)</td>
<td align="center" valign="middle">57.71(55.21&#x2013;60.17)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Female</td>
<td align="center" valign="middle">54.05(52.73&#x2013;55.37)</td>
<td align="center" valign="middle">67.49(64.87&#x2013;70.00)</td>
<td align="center" valign="middle">58.58(55.89&#x2013;61.22)</td>
<td align="center" valign="middle">50.59(47.98&#x2013;53.21)</td>
<td align="center" valign="middle">42.29(39.83&#x2013;44.79)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Race</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">Mexican American</td>
<td align="center" valign="middle">4.41(4.13&#x2013;4.71)</td>
<td align="center" valign="middle">5.52(4.83&#x2013;6.30)</td>
<td align="center" valign="middle">4.54(4.00&#x2013;5.15)</td>
<td align="center" valign="middle">4.32(3.81&#x2013;4.90)</td>
<td align="center" valign="middle">3.48(3.01&#x2013;4.02)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Hispanic</td>
<td align="center" valign="middle">3.86(3.59&#x2013;4.14)</td>
<td align="center" valign="middle">4.63(4.04&#x2013;5.29)</td>
<td align="center" valign="middle">4.03(3.52&#x2013;4.62)</td>
<td align="center" valign="middle">3.59(3.09&#x2013;4.17)</td>
<td align="center" valign="middle">3.33(2.84&#x2013;3.90)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Non-Hispanic White</td>
<td align="center" valign="middle">76.87(76.02&#x2013;77.69)</td>
<td align="center" valign="middle">62.44(60.09&#x2013;64.73)</td>
<td align="center" valign="middle">77.76(76.07&#x2013;79.37)</td>
<td align="center" valign="middle">80.43(78.86&#x2013;81.91)</td>
<td align="center" valign="middle">83.87(82.52&#x2013;85.15)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Non-Hispanic Black</td>
<td align="center" valign="middle">9.15(8.72&#x2013;9.60)</td>
<td align="center" valign="middle">19.40(17.97&#x2013;20.93)</td>
<td align="center" valign="middle">8.27(7.49&#x2013;9.13)</td>
<td align="center" valign="middle">6.17(5.53&#x2013;6.88)</td>
<td align="center" valign="middle">4.86(4.28&#x2013;5.50)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Other race</td>
<td align="center" valign="middle">5.72(5.22&#x2013;6.27)</td>
<td align="center" valign="middle">8.02(6.82&#x2013;9.41)</td>
<td align="center" valign="middle">5.39(4.42&#x2013;6.55)</td>
<td align="center" valign="middle">5.49(4.53&#x2013;6.64)</td>
<td align="center" valign="middle">4.46(3.69&#x2013;5.39)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Education</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="middle">0.010</td>
</tr>
<tr>
<td align="left" valign="middle">&#x003C;&#x2009;High school</td>
<td align="center" valign="middle">17.66(16.86&#x2013;18.49)</td>
<td align="center" valign="middle">19.21(17.53&#x2013;21.02)</td>
<td align="center" valign="middle">15.73(14.26&#x2013;17.33)</td>
<td align="center" valign="middle">17.49(15.96&#x2013;19.13)</td>
<td align="center" valign="middle">18.53(16.91&#x2013;20.27)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">High school</td>
<td align="center" valign="middle">25.38(24.25&#x2013;26.55)</td>
<td align="center" valign="middle">24.56(22.28&#x2013;26.99)</td>
<td align="center" valign="middle">25.10(22.83&#x2013;27.52)</td>
<td align="center" valign="middle">25.40(23.16&#x2013;27.78)</td>
<td align="center" valign="middle">26.30(24.16&#x2013;28.55)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">&#x003E;&#x2009;High school</td>
<td align="center" valign="middle">56.96(55.67&#x2013;58.23)</td>
<td align="center" valign="middle">56.23(53.54&#x2013;58.88)</td>
<td align="center" valign="middle">59.16(56.57&#x2013;61.71)</td>
<td align="center" valign="middle">57.11(54.56&#x2013;59.63)</td>
<td align="center" valign="middle">55.18(52.70&#x2013;57.62)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Marital status</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="middle">0.003</td>
</tr>
<tr>
<td align="left" valign="middle">Married/living with a partner</td>
<td align="center" valign="middle">62.53(61.29&#x2013;63.76)</td>
<td align="center" valign="middle">61.06(58.44&#x2013;63.61)</td>
<td align="center" valign="middle">63.50(60.98&#x2013;65.95)</td>
<td align="center" valign="middle">63.27(60.78&#x2013;65.68)</td>
<td align="center" valign="middle">62.00(59.61&#x2013;64.33)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Never married</td>
<td align="center" valign="middle">6.33(5.74&#x2013;6.98)</td>
<td align="center" valign="middle">8.21(6.91&#x2013;9.74)</td>
<td align="center" valign="middle">5.53(4.53&#x2013;6.72)</td>
<td align="center" valign="middle">5.86(4.81&#x2013;7.13)</td>
<td align="center" valign="middle">6.11(4.94&#x2013;7.55)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Separated/divorced/widowed</td>
<td align="center" valign="middle">31.14(29.99&#x2013;32.31)</td>
<td align="center" valign="middle">30.73(28.41&#x2013;33.15)</td>
<td align="center" valign="middle">30.98(28.67&#x2013;33.39)</td>
<td align="center" valign="middle">30.87(28.60&#x2013;33.24)</td>
<td align="center" valign="middle">31.89(29.73&#x2013;34.12)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Income poverty ratio</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">&#x003C;&#x2009;1.3</td>
<td align="center" valign="middle">22.10(21.20&#x2013;23.03)</td>
<td align="center" valign="middle">25.54(23.56&#x2013;27.63)</td>
<td align="center" valign="middle">20.46(18.72&#x2013;22.31)</td>
<td align="center" valign="middle">21.27(19.57&#x2013;23.07)</td>
<td align="center" valign="middle">21.85(20.11&#x2013;23.70)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">(1.3&#x2013;3.5)</td>
<td align="center" valign="middle">38.41(37.15&#x2013;39.68)</td>
<td align="center" valign="middle">37.34(34.73&#x2013;40.02)</td>
<td align="center" valign="middle">35.97(33.51&#x2013;38.51)</td>
<td align="center" valign="middle">37.64(35.19&#x2013;40.15)</td>
<td align="center" valign="middle">42.47(40.03&#x2013;44.94)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">&#x2265;3.5</td>
<td align="center" valign="middle">39.49(38.13&#x2013;40.86)</td>
<td align="center" valign="middle">37.12(34.31&#x2013;40.02)</td>
<td align="center" valign="middle">43.57(40.83&#x2013;46.35)</td>
<td align="center" valign="middle">41.09(38.42&#x2013;43.82)</td>
<td align="center" valign="middle">35.68(33.15&#x2013;38.29)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Smoke</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">Yes</td>
<td align="center" valign="middle">52.84(51.52&#x2013;54.16)</td>
<td align="center" valign="middle">45.96(43.23&#x2013;48.72)</td>
<td align="center" valign="middle">49.30(46.62&#x2013;51.99)</td>
<td align="center" valign="middle">55.08(52.45&#x2013;57.68)</td>
<td align="center" valign="middle">59.60(57.11&#x2013;62.05)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">No</td>
<td align="center" valign="middle">47.16(45.84&#x2013;48.48)</td>
<td align="center" valign="middle">54.04(51.28&#x2013;56.77)</td>
<td align="center" valign="middle">50.70(48.01&#x2013;53.38)</td>
<td align="center" valign="middle">44.92(42.32&#x2013;47.55)</td>
<td align="center" valign="middle">40.40(37.95&#x2013;42.89)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Alcohol use</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">Yes</td>
<td align="center" valign="middle">75.92(74.86&#x2013;76.94)</td>
<td align="center" valign="middle">71.09(68.66&#x2013;73.41)</td>
<td align="center" valign="middle">76.16(74.03&#x2013;78.16)</td>
<td align="center" valign="middle">77.10(75.07&#x2013;79.01)</td>
<td align="center" valign="middle">78.32(76.34&#x2013;80.18)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">No</td>
<td align="center" valign="middle">24.08(23.06&#x2013;25.14)</td>
<td align="center" valign="middle">28.91(26.59&#x2013;31.34)</td>
<td align="center" valign="middle">23.84(21.84&#x2013;25.97)</td>
<td align="center" valign="middle">22.90(20.99&#x2013;24.93)</td>
<td align="center" valign="middle">21.68(19.82&#x2013;23.66)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Frailty</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">No</td>
<td align="center" valign="middle">63.54(62.3&#x2013;64.76)</td>
<td align="center" valign="middle">65.04(62.45&#x2013;67.53)</td>
<td align="center" valign="middle">70.52(68.13&#x2013;72.80)</td>
<td align="center" valign="middle">65.57(63.15&#x2013;67.92)</td>
<td align="center" valign="middle">53.31(50.82&#x2013;55.79)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Yes</td>
<td align="center" valign="middle">36.46(35.24&#x2013;37.7)</td>
<td align="center" valign="middle">34.96(32.47&#x2013;37.55)</td>
<td align="center" valign="middle">29.48(27.20&#x2013;31.87)</td>
<td align="center" valign="middle">34.43(32.08&#x2013;36.85)</td>
<td align="center" valign="middle">46.69(44.21&#x2013;49.18)</td>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
<p>Stratifying by different levels of lnSII, significant differences in frailty, race, education, marital status, income and poverty ratio, and smoking status were observed (<italic>p</italic>&#x2009;&#x003C;&#x2009;0.05). The proportions of the four frailty categories were 35.91, 31.12, 33.05, and 45.35%, as illustrated in <xref ref-type="table" rid="tab3">Table 3</xref>.</p>
<table-wrap position="float" id="tab3"><label>Table 3</label>
<caption>
<p>Baseline characteristics of the study population stratified by quartiles of lnSII value.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="top">lnSII total</th>
<th align="center" valign="top">Q1(&#x2264;5.78)</th>
<th align="center" valign="top">Q2(5.78&#x2013;6.14)</th>
<th align="center" valign="top">Q3(6.14&#x2013;6.5)</th>
<th align="center" valign="top">Q4(&#x2265;6.5)</th>
<th align="center" valign="top"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Sample size</td>
<td align="center" valign="middle">11,234</td>
<td align="center" valign="middle">2,808</td>
<td align="center" valign="middle">2,808</td>
<td align="center" valign="middle">2,808</td>
<td align="center" valign="middle">2,810</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Year</td>
<td align="center" valign="middle">64.75&#x2009;&#x00B1;&#x2009;0.13</td>
<td align="center" valign="middle">64.54&#x2009;&#x00B1;&#x2009;0.26</td>
<td align="center" valign="middle">64.50&#x2009;&#x00B1;&#x2009;0.26</td>
<td align="center" valign="middle">64.91&#x2009;&#x00B1;&#x2009;0.26</td>
<td align="center" valign="middle">65.00&#x2009;&#x00B1;&#x2009;0.26</td>
<td align="center" valign="middle">0.170</td>
</tr>
<tr>
<td align="left" valign="middle">Gender</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="middle">0.924</td>
</tr>
<tr>
<td align="left" valign="middle">Male</td>
<td align="center" valign="middle">45.95(44.63&#x2013;47.27)</td>
<td align="center" valign="middle">46.39(43.64&#x2013;49.15)</td>
<td align="center" valign="middle">46.17(43.52&#x2013;48.85)</td>
<td align="center" valign="middle">45.80(43.18&#x2013;48.44)</td>
<td align="center" valign="middle">45.53(43.04&#x2013;48.05)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Female</td>
<td align="center" valign="middle">54.05(52.73&#x2013;55.37)</td>
<td align="center" valign="middle">53.61(50.85&#x2013;56.36)</td>
<td align="center" valign="middle">53.83(51.15&#x2013;56.48)</td>
<td align="center" valign="middle">54.20(51.56&#x2013;56.82)</td>
<td align="center" valign="middle">54.47(51.95&#x2013;56.96)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Race</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">Mexican American</td>
<td align="center" valign="middle">4.41(4.13&#x2013;4.71)</td>
<td align="center" valign="middle">4.65(4.05&#x2013;5.33)</td>
<td align="center" valign="middle">4.83(4.25&#x2013;5.49)</td>
<td align="center" valign="middle">4.40(3.88&#x2013;4.98)</td>
<td align="center" valign="middle">3.81(3.31&#x2013;4.37)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Hispanic</td>
<td align="center" valign="middle">3.86(3.59&#x2013;4.14)</td>
<td align="center" valign="middle">4.12(3.57&#x2013;4.74)</td>
<td align="center" valign="middle">4.32(3.76&#x2013;4.95)</td>
<td align="center" valign="middle">3.48(3.02&#x2013;4.01)</td>
<td align="center" valign="middle">3.57(3.06&#x2013;4.18)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Non-Hispanic White</td>
<td align="center" valign="middle">76.87(76.02&#x2013;77.69)</td>
<td align="center" valign="middle">67.51(65.32&#x2013;69.62)</td>
<td align="center" valign="middle">76.17(74.46&#x2013;77.81)</td>
<td align="center" valign="middle">79.91(78.35&#x2013;81.39)</td>
<td align="center" valign="middle">82.10(80.65&#x2013;83.47)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Non-Hispanic Black</td>
<td align="center" valign="middle">9.15(8.72&#x2013;9.60)</td>
<td align="center" valign="middle">16.92(15.62&#x2013;18.31)</td>
<td align="center" valign="middle">8.68(7.87&#x2013;9.57)</td>
<td align="center" valign="middle">6.89(6.19&#x2013;7.67)</td>
<td align="center" valign="middle">5.53(4.92&#x2013;6.20)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Other race</td>
<td align="center" valign="middle">5.72(5.22&#x2013;6.27)</td>
<td align="center" valign="middle">6.80(5.57&#x2013;8.28)</td>
<td align="center" valign="middle">6.00(5.08&#x2013;7.06)</td>
<td align="center" valign="middle">5.32(4.40&#x2013;6.41)</td>
<td align="center" valign="middle">4.99(4.14&#x2013;6.00)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Education</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="middle">0.013</td>
</tr>
<tr>
<td align="left" valign="middle">&#x003C;&#x2009;High school</td>
<td align="center" valign="middle">17.66(16.86&#x2013;18.49)</td>
<td align="center" valign="middle">19.18(17.49&#x2013;20.99)</td>
<td align="center" valign="middle">16.47(14.96&#x2013;18.10)</td>
<td align="center" valign="middle">17.19(15.64&#x2013;18.87)</td>
<td align="center" valign="middle">18.03(16.47&#x2013;19.70)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">High school</td>
<td align="center" valign="middle">25.38(24.25&#x2013;26.55)</td>
<td align="center" valign="middle">25.49(23.14&#x2013;28.00)</td>
<td align="center" valign="middle">23.95(21.80&#x2013;26.23)</td>
<td align="center" valign="middle">26.88(24.55&#x2013;29.35)</td>
<td align="center" valign="middle">25.20(23.09&#x2013;27.42)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">&#x003E;&#x2009;High school</td>
<td align="center" valign="middle">56.96(55.67&#x2013;58.23)</td>
<td align="center" valign="middle">55.33(52.62&#x2013;58.01)</td>
<td align="center" valign="middle">59.58(57.04&#x2013;62.07)</td>
<td align="center" valign="middle">55.92(53.33&#x2013;58.49)</td>
<td align="center" valign="middle">56.77(54.31&#x2013;59.21)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Marital status</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">Married/living with a partner</td>
<td align="center" valign="middle">62.53(61.29&#x2013;63.76)</td>
<td align="center" valign="middle">61.91(59.32&#x2013;64.43)</td>
<td align="center" valign="middle">66.82(64.41&#x2013;69.15)</td>
<td align="center" valign="middle">61.57(59.05&#x2013;64.04)</td>
<td align="center" valign="middle">59.87(57.42&#x2013;62.27)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Never married</td>
<td align="center" valign="middle">6.33(5.74&#x2013;6.98)</td>
<td align="center" valign="middle">7.86(6.58&#x2013;9.37)</td>
<td align="center" valign="middle">4.98(4.02&#x2013;6.15)</td>
<td align="center" valign="middle">5.96(4.90&#x2013;7.23)</td>
<td align="center" valign="middle">6.75(5.55&#x2013;8.19)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Separated/divorced/widowed</td>
<td align="center" valign="middle">31.14(29.99&#x2013;32.31)</td>
<td align="center" valign="middle">30.23(27.94&#x2013;32.62)</td>
<td align="center" valign="middle">28.20(26.02&#x2013;30.49)</td>
<td align="center" valign="middle">32.46(30.13&#x2013;34.89)</td>
<td align="center" valign="middle">33.38(31.14&#x2013;35.69)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Income poverty ratio</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="middle">0.002</td>
</tr>
<tr>
<td align="left" valign="middle">&#x003C;&#x2009;1.3</td>
<td align="center" valign="middle">22.10(21.20&#x2013;23.03)</td>
<td align="center" valign="middle">24.25(22.32&#x2013;26.30)</td>
<td align="center" valign="middle">21.14(19.37&#x2013;23.02)</td>
<td align="center" valign="middle">20.52(18.84&#x2013;22.30)</td>
<td align="center" valign="middle">22.84(21.08&#x2013;24.71)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">(1.3&#x2013;3.5)</td>
<td align="center" valign="middle">38.41(37.15&#x2013;39.68)</td>
<td align="center" valign="middle">37.69(35.09&#x2013;40.36)</td>
<td align="center" valign="middle">37.17(34.71&#x2013;39.70)</td>
<td align="center" valign="middle">39.01(36.51&#x2013;41.57)</td>
<td align="center" valign="middle">39.58(37.16&#x2013;42.04)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">&#x2265;3.5</td>
<td align="center" valign="middle">39.49(38.13&#x2013;40.86)</td>
<td align="center" valign="middle">38.06(35.24&#x2013;40.96)</td>
<td align="center" valign="middle">41.69(38.97&#x2013;44.47)</td>
<td align="center" valign="middle">40.47(37.79&#x2013;43.21)</td>
<td align="center" valign="middle">37.58(35.00&#x2013;40.23)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Smoke</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">Yes</td>
<td align="center" valign="middle">52.84(51.52&#x2013;54.16)</td>
<td align="center" valign="middle">50.00(47.24&#x2013;52.76)</td>
<td align="center" valign="middle">49.35(46.69&#x2013;52.01)</td>
<td align="center" valign="middle">53.61(50.97&#x2013;56.24)</td>
<td align="center" valign="middle">57.72(55.20&#x2013;60.21)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">No</td>
<td align="center" valign="middle">47.16(45.84&#x2013;48.48)</td>
<td align="center" valign="middle">50.00(47.24&#x2013;52.76)</td>
<td align="center" valign="middle">50.65(47.99&#x2013;53.31)</td>
<td align="center" valign="middle">46.39(43.76&#x2013;49.03)</td>
<td align="center" valign="middle">42.28(39.79&#x2013;44.80)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Alcohol use</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="middle">0.311</td>
</tr>
<tr>
<td align="left" valign="middle">Yes</td>
<td align="center" valign="middle">75.92(74.86&#x2013;76.94)</td>
<td align="center" valign="middle">74.71(72.45&#x2013;76.84)</td>
<td align="center" valign="middle">75.63(73.43&#x2013;77.71)</td>
<td align="center" valign="middle">76.27(74.17&#x2013;78.24)</td>
<td align="center" valign="middle">76.82(74.83&#x2013;78.69)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">No</td>
<td align="center" valign="middle">24.08(23.06&#x2013;25.14)</td>
<td align="center" valign="middle">25.29(23.16&#x2013;27.55)</td>
<td align="center" valign="middle">24.37(22.29&#x2013;26.57)</td>
<td align="center" valign="middle">23.73(21.76&#x2013;25.83)</td>
<td align="center" valign="middle">23.18(21.31&#x2013;25.17)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Frailty</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
</tr>
<tr>
<td align="left" valign="middle">No</td>
<td align="center" valign="middle">63.54(62.3&#x2013;64.76)</td>
<td align="center" valign="middle">64.09(61.44&#x2013;66.65)</td>
<td align="center" valign="middle">68.88(66.49&#x2013;71.18)</td>
<td align="center" valign="middle">66.95(64.56&#x2013;69.27)</td>
<td align="center" valign="middle">54.65(52.15&#x2013;57.13)</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Yes</td>
<td align="center" valign="middle">36.46(35.24&#x2013;37.7)</td>
<td align="center" valign="middle">35.91(33.35&#x2013;38.56)</td>
<td align="center" valign="middle">31.12(28.82&#x2013;33.51)</td>
<td align="center" valign="middle">33.05(30.73&#x2013;35.44)</td>
<td align="center" valign="middle">45.35(42.87&#x2013;47.85)</td>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="sec14"><label>3.2</label>
<title>The relationship between lnSII, lnSIRI and frailty</title>
<p>Three weighted logistic regression models were employed to investigate the association between lnSII, lnSIRI, and frailty. The odds ratios (OR) and 95% confidence intervals (CI) for the ratio of frailty&#x2019;s correlation with lnSII and lnSIRI are presented in <xref ref-type="table" rid="tab4">Table 4</xref>. Model 1, unadjusted; Model 2, adjusted for age, gender, race, education, marital status, income-to-poverty ratio; Model 3, additional adjustment for smoking and drinking status based on Model 2. There is a consistently significant positive correlation between lnSII, lnSIRI, and frailty in all three models. The impact of lnSII on frailty was as follows: Model 1 (OR&#x2009;=&#x2009;1.34, 95% CI: 1.21&#x2013;1.48), Model 2 (OR&#x2009;=&#x2009;1.41, 95% CI: 1.26&#x2013;1.57), Model 3 (OR&#x2009;=&#x2009;1.38, 95% CI: 1.24&#x2013;1.54). When assessing different levels of lnSII, compared to the second quartile of lnSII, the first and third quartiles did not show a significant difference in the probability of frailty. At the same time, the likelihood significantly increased in the fourth quartile: Model 1 (OR&#x2009;=&#x2009;1.84, 95% CI: 1.58&#x2013;2.13), Model 2 (OR&#x2009;=&#x2009;1.86, 95% CI: 1.59&#x2013;2.17), Model 3 (OR&#x2009;=&#x2009;1.82, 95% CI: 1.55&#x2013;2.12). Furthermore, the trend <italic>p</italic>-values for all three models were below 0.001.</p>
<table-wrap position="float" id="tab4"><label>Table 4</label>
<caption>
<p>Association between lnSII, lnSIRI and frailty.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="middle">Model 1<break/>OR (95% CI)</th>
<th align="center" valign="middle"><italic>p</italic>-value</th>
<th align="center" valign="middle">Model 2<break/>OR (95% CI)</th>
<th align="center" valign="middle"><italic>p</italic>-value</th>
<th align="center" valign="middle">Model 3<break/>OR (95% CI)</th>
<th align="center" valign="middle"><italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">lnSII</td>
<td align="center" valign="middle">1.34(1.21&#x2013;1.48)</td>
<td align="center" valign="middle">&#x003C;0.0001</td>
<td align="center" valign="middle">1.41(1.26&#x2013;1.57)</td>
<td align="center" valign="middle">&#x003C;0.0001</td>
<td align="center" valign="middle">1.38(1.24&#x2013;1.54)</td>
<td align="center" valign="middle">&#x003C;0.0001</td>
</tr>
<tr>
<td align="left" valign="middle">lnSII quartiles</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Q1(&#x2264;5.78)</td>
<td align="center" valign="middle">1.24(1.06&#x2013;1.45)</td>
<td align="center" valign="middle">0.0073</td>
<td align="center" valign="middle">1.16(0.98&#x2013;1.36)</td>
<td align="center" valign="middle">0.0787</td>
<td align="center" valign="middle">1.16(0.99&#x2013;1.37)</td>
<td align="center" valign="middle">0.071</td>
</tr>
<tr>
<td align="left" valign="middle">Q2(5.78&#x2013;6.14)</td>
<td align="center" valign="middle">Reference</td>
<td align="center" valign="middle">Reference</td>
<td align="center" valign="middle">Reference</td>
<td align="center" valign="middle">Reference</td>
<td align="center" valign="middle">Reference</td>
<td align="center" valign="middle">Reference</td>
</tr>
<tr>
<td align="left" valign="middle">Q3(6.14&#x2013;6.5)</td>
<td align="center" valign="middle">1.09(0.94&#x2013;1.27)</td>
<td align="center" valign="middle">0.2562</td>
<td align="center" valign="middle">1.09(0.93&#x2013;1.27)</td>
<td align="center" valign="middle">0.309</td>
<td align="center" valign="middle">1.07(0.92&#x2013;1.26)</td>
<td align="center" valign="middle">0.3854</td>
</tr>
<tr>
<td align="left" valign="middle">Q4(&#x2265;6.5)</td>
<td align="center" valign="middle">1.84(1.58&#x2013;2.13)</td>
<td align="center" valign="middle">&#x003C;0.0001</td>
<td align="center" valign="middle">1.86(1.59&#x2013;2.17)</td>
<td align="center" valign="middle">&#x003C;0.0001</td>
<td align="center" valign="middle">1.82(1.55&#x2013;2.12)</td>
<td align="center" valign="middle">&#x003C;0.0001</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>p</italic> trend</td>
<td align="center" valign="middle">&#x003C;0.001</td>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
<td/>
</tr>
<tr>
<td align="left" valign="middle">lnSIRI</td>
<td align="center" valign="middle">1.45(1.32&#x2013;1.58)</td>
<td align="center" valign="middle">&#x003C;0.0001</td>
<td align="center" valign="middle">1.73(1.56&#x2013;1.91)</td>
<td align="center" valign="middle">&#x003C;0.0001</td>
<td align="center" valign="middle">1.69(1.53&#x2013;1.88)</td>
<td align="center" valign="middle">&#x003C;0.0001</td>
</tr>
<tr>
<td align="left" valign="middle">lnSIRI quartiles</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td align="left" valign="middle">Q1(&#x2265;&#x2009;&#x2212;&#x2009;0.29)</td>
<td align="center" valign="middle">1.29(1.10&#x2013;1.51)</td>
<td align="center" valign="middle">0.0019</td>
<td align="center" valign="middle">1.09(0.93&#x2013;1.29)</td>
<td align="center" valign="middle">0.2897</td>
<td align="center" valign="middle">1.10(0.94&#x2013;1.30)</td>
<td align="center" valign="middle">0.2367</td>
</tr>
<tr>
<td align="left" valign="middle">Q2(&#x2212;0.29 to 0.11)</td>
<td align="center" valign="middle">Reference</td>
<td align="center" valign="middle">Reference</td>
<td align="center" valign="middle">Reference</td>
<td align="center" valign="middle">Reference</td>
<td align="center" valign="middle">Reference</td>
<td align="center" valign="middle">Reference</td>
</tr>
<tr>
<td align="left" valign="middle">Q3(0.11&#x2013;0.52)</td>
<td align="center" valign="middle">1.26(1.08&#x2013;1.47)</td>
<td align="center" valign="middle">0.0038</td>
<td align="center" valign="middle">1.32(1.12&#x2013;1.55)</td>
<td align="center" valign="middle">0.0008</td>
<td align="center" valign="middle">1.30(1.10&#x2013;1.53)</td>
<td align="center" valign="middle">0.0016</td>
</tr>
<tr>
<td align="left" valign="middle">Q4(&#x2265;0.52)</td>
<td align="center" valign="middle">2.09(1.80&#x2013;2.44)</td>
<td align="center" valign="middle">&#x003C;0.0001</td>
<td align="center" valign="middle">2.34(1.99&#x2013;2.76)</td>
<td align="center" valign="middle">&#x003C;0.0001</td>
<td align="center" valign="middle">2.29(1.95&#x2013;2.70)</td>
<td align="center" valign="middle">&#x003C;0.0001</td>
</tr>
<tr>
<td align="left" valign="middle"><italic>p</italic> trend</td>
<td align="center" valign="middle">&#x003C;0.001</td>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
<td/>
<td align="center" valign="middle">&#x003C;0.001</td>
<td/>
</tr>
</tbody>
</table>
</table-wrap>
<p>The impact of lnSIRI on frailty was as follows: Model 1 (OR&#x2009;=&#x2009;1.45, 95% CI: 1.32&#x2013;1.58), Model 2 (OR&#x2009;=&#x2009;1.73, 95% CI: 1.56&#x2013;1.91), and Model 3 (OR&#x2009;=&#x2009;1.69, 95% CI: 1.53&#x2013;1.88). When assessing different levels of lnSIRI, compared to the second quartile of lnSIRI, the first quartile did not show a significant difference in the probability of frailty. In contrast, the probabilities significantly increased in the third and fourth quartiles. For the third quartile: Model 1 (OR&#x2009;=&#x2009;1.26, 95% CI: 1.08&#x2013;1.47), Model 2 (OR&#x2009;=&#x2009;1.32, 95% CI: 1.12&#x2013;1.55), Model 3 (OR&#x2009;=&#x2009;1.30, 95% CI: 1.10&#x2013;1.53); For the fourth quartile: Model 1 (OR&#x2009;=&#x2009;2.09, 95% CI: 1.80&#x2013;2.44), Model 2 (OR&#x2009;=&#x2009;2.34, 95% CI: 1.99&#x2013;2.76), Model 3 (OR&#x2009;=&#x2009;2.29, 95% CI: 1.95&#x2013;2.70). Furthermore, the trend <italic>p</italic>-values for all three models were below 0.001.</p>
<p>We also used RCS to visualize the association between lnSII, lnSIRI, and frailty. After adjusting for all covariates in the primary analysis Model 3 mentioned above, we observed a non-linear correlation between lnSII, lnSIRI, and frailty (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p>
<fig position="float" id="fig2"><label>Figure 2</label>
<caption>
<p>RCS analysis of lnSII <bold>(A)</bold> and lnSIRI <bold>(B)</bold> with the odds ratio of frailty.</p>
</caption>
<graphic xlink:href="fpubh-12-1377408-g002.tif"/>
</fig>
</sec>
<sec id="sec15"><label>3.3</label>
<title>Stratified analyses and interaction test</title>
<p>The interaction tests in the subgroup analysis revealed that the impact of lnSIRI on frailty varied with age (<italic>p</italic> for interaction&#x2009;=&#x2009;0.007) and income-to-poverty ratio (<italic>p</italic> for interaction &#x003C;0.001). However, gender, race, education, marital status, smoking, and alcohol consumption did not influence this positive correlation (<italic>p</italic> for interaction &#x003E;0.05), as illustrated in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p>
<fig position="float" id="fig3"><label>Figure 3</label>
<caption>
<p>Subgroup analysis and interaction of the association between lnSIRI and frailty.</p>
</caption>
<graphic xlink:href="fpubh-12-1377408-g003.tif"/>
</fig>
<p>The relationship between lnSII and frailty showed no statistically significant differences across different strata, indicating that age, gender, race, education, marital status, income-to-poverty ratio, smoking, and alcohol consumption did not significantly affect this positive correlation (<italic>p</italic> for interaction &#x003E;0.05), as depicted in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</p>
<fig position="float" id="fig4"><label>Figure 4</label>
<caption>
<p>Subgroup analysis and interaction of the association between lnSII and frailty.</p>
</caption>
<graphic xlink:href="fpubh-12-1377408-g004.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec16"><label>4</label>
<title>Discussion</title>
<p>This cross-sectional study investigated the relationship between lnSII, lnSIRI, and frailty using weighted logistic regression. We included 11,234 adults aged 40&#x2009;years and older. The study&#x2019;s results indicated a positive correlation between lnSII and lnSIRI with frailty. This finding aligns with previous research, which suggested that individuals with higher neutrophil-to-lymphocyte ratio and higher SII levels have an increased risk of frailty events (<xref ref-type="bibr" rid="ref17">17</xref>). Furthermore, our study revealed that age and income poverty ratio influence the association between lnSIRI and frailty. In contrast, the association between lnSII and frailty is relatively unaffected by other factors. We also observed several differences between frail and non-frail individuals. Frail individuals were more likely to be female, have lower educational attainment, lower income poverty ratio, less likely to be married/cohabiting, smokers, and had higher levels of lnSII and lnSIRI. Previous studies have also shown that the frail group is more likely to be female, have lower educational attainment, and have lower income (<xref ref-type="bibr" rid="ref31">31</xref>, <xref ref-type="bibr" rid="ref32">32</xref>).</p>
<p>Research indicates that the prevalence of frailty among older adults is between 12 and 24% in 62 countries and regions (<xref ref-type="bibr" rid="ref33">33</xref>). Frailty has been shown to have varying degrees of impact on the prognosis of older adults with cardiovascular diseases, increasing the incidence and mortality rates of cardiovascular disease patients (<xref ref-type="bibr" rid="ref34">34</xref>). It becomes an independent risk factor for various major adverse cardiovascular events, including death, stroke, readmission for heart failure, and postoperative cardiac complications (<xref ref-type="bibr" rid="ref35">35</xref>). Additionally, frail patients are at a higher risk of developing sepsis, pneumonia, and kidney failure compared to non-frail individuals (<xref ref-type="bibr" rid="ref36">36</xref>). However, the pathological mechanisms leading to frailty remain unclear, and there is a lack of recognized, accurate, and reliable biological markers for frailty (<xref ref-type="bibr" rid="ref37 ref38 ref39">37&#x2013;39</xref>). Future research efforts should focus on understanding the pathogenesis of frailty to improve early diagnosis and intervention, thereby alleviating the burden on global healthcare systems.</p>
<p>The study points out that elevated levels of inflammatory markers are commonly found in older adults, and inflammation may be a primary factor leading to frailty (<xref ref-type="bibr" rid="ref40">40</xref>, <xref ref-type="bibr" rid="ref41">41</xref>). The association between changes in the immune system and frailty involves multiple pathways, with neutrophils being a crucial biomarker for innate immunity, platelets potentially contributing to immune function, and lymphocytes providing rich information about adaptive immunity (<xref ref-type="bibr" rid="ref42">42</xref>, <xref ref-type="bibr" rid="ref43">43</xref>). SII and SIRI have demonstrated exceptional validity as emerging biomarkers in various diseases (<xref ref-type="bibr" rid="ref44">44</xref>). SII&#x2019;s predictive ability for major cardiovascular events in coronary heart disease patients undergoing coronary intervention surpasses traditional risk factors (<xref ref-type="bibr" rid="ref45">45</xref>). Both SII and SIRI are closely correlated with cardiovascular and all-cause mortality. These studies emphasize the role of managing inflammatory markers in frailty among middle-aged and older adults and suggest that emerging biomarkers like SII and SIRI could be powerful tools for assessing and managing the health of middle-aged and older individuals (<xref ref-type="bibr" rid="ref46">46</xref>, <xref ref-type="bibr" rid="ref47">47</xref>).</p>
<p>The findings of this study reveal a positive correlation between SII and SIRI with frailty, especially with SIRI exhibiting a more significant association. The study holds general significance due to its large sample size and representative sample selection. However, it is essential to note some limitations. Firstly, the study adopts a cross-sectional design, thus preventing the establishment of a causal relationship between SII, SIRI, and frailty. Secondly, some unaccounted confounding factors could impact the accurate assessment of the genuine associations.</p>
</sec>
<sec sec-type="conclusions" id="sec17"><label>5</label>
<title>Conclusion</title>
<p>This cross-sectional study provides compelling evidence indicating a positive correlation between systemic inflammatory biomarkers (SIRI and SII) and frailty. Given the ease of assessment of SIRI and SII in the laboratory, they can serve as cost-effective predictive factors for future frailty occurrences. This offers feasibility and guiding information for further interventions targeting the immune system to reduce the incidence of frailty.</p>
</sec>
<sec sec-type="data-availability" id="sec18">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">Supplementary material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="author-contributions" id="sec19">
<title>Author contributions</title>
<p>HZ: Conceptualization, Data curation, Methodology, Software, Visualization, Writing &#x2013; original draft. XL: Supervision, Writing &#x2013; review &#x0026; editing. XW: Data curation, Visualization, Writing &#x2013; original draft. YJ: Conceptualization, Supervision, Validation, Visualization, Writing &#x2013; review &#x0026; editing.</p>
</sec>
</body>
<back>
<sec sec-type="funding-information" id="sec20">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<ack>
<p>We appreciate the people who contributed to the NHANES data we studied.</p>
</ack>
<sec sec-type="COI-statement" id="sec21">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec22">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fpubh.2024.1377408/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fpubh.2024.1377408/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr"><p>NHANES, National Health and Nutrition Examination Survey; SII, Systemic Immune-Inflammation Index; SIRI, Systemic Inflammatory Response Index; RCS, restricted cubic spline; OR, odds ratio; CI, confidence interval; ln, natural logarithm; FI, Frailty Index.</p></fn>
</fn-group>
<fn-group>
<fn id="fn0001">
<p><sup>1</sup><ext-link xlink:href="https://www.cdc.gov/nchs/nhanes/index.htm" ext-link-type="uri">https://www.cdc.gov/nchs/nhanes/index.htm</ext-link>
</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>Z</given-names></name> <name><surname>Wang</surname> <given-names>J</given-names></name> <name><surname>Cai</surname> <given-names>X</given-names></name> <name><surname>Wang</surname> <given-names>P</given-names></name> <name><surname>Liu</surname> <given-names>S</given-names></name></person-group>. <article-title>L-shaped association of serum &#x03B1;-klotho and frailty among the middle-aged and older adults: results from NHANES 2007-2016</article-title>. <source>BMC Geriatr</source>. (<year>2023</year>) <volume>23</volume>:<fpage>716</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12877-023-04324-z</pub-id></citation></ref>
<ref id="ref2"><label>2.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>G</given-names></name> <name><surname>Qian</surname> <given-names>D</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Qu</surname> <given-names>G</given-names></name> <name><surname>Qian</surname> <given-names>Y</given-names></name> <name><surname>Pei</surname> <given-names>B</given-names></name></person-group>. <article-title>The association between frailty and osteoarthritis based on the NHANES and Mendelian randomization study</article-title>. <source>Arch Med Sci</source>. (<year>2023</year>) <volume>19</volume>:<fpage>1545</fpage>&#x2013;<lpage>50</lpage>. doi: <pub-id pub-id-type="doi">10.5114/aoms/171270</pub-id>, PMID: <pub-id pub-id-type="pmid">37732065</pub-id></citation></ref>
<ref id="ref3"><label>3.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bilgin</surname> <given-names>S</given-names></name> <name><surname>Aktas</surname> <given-names>G</given-names></name> <name><surname>Kurtkulagi</surname> <given-names>O</given-names></name> <name><surname>Atak</surname> <given-names>BM</given-names></name> <name><surname>Duman</surname> <given-names>TT</given-names></name></person-group>. <article-title>Edmonton frail score is associated with diabetic control in elderly type 2 diabetic subjects</article-title>. <source>J Diabetes Metab Disord</source>. (<year>2020</year>) <volume>19</volume>:<fpage>511</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s40200-020-00542-z</pub-id>, PMID: <pub-id pub-id-type="pmid">32550203</pub-id></citation></ref>
<ref id="ref4"><label>4.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aktas</surname> <given-names>G</given-names></name></person-group>. <article-title>Importance of the geriatric nutritional risk index in survival among the geriatric population</article-title>. <source>Geriatr Gerontol Int</source>. (<year>2024</year>). doi: <pub-id pub-id-type="doi">10.1111/ggi.14836</pub-id>, PMID: <pub-id pub-id-type="pmid">38463345</pub-id></citation></ref>
<ref id="ref5"><label>5.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>X</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Shen</surname> <given-names>L</given-names></name> <name><surname>Sun</surname> <given-names>Y</given-names></name> <name><surname>Zeng</surname> <given-names>B</given-names></name> <name><surname>Zhu</surname> <given-names>B</given-names></name> <etal/></person-group>. <article-title>Association between frailty and chronic constipation and chronic diarrhea among American older adults: National Health and nutrition examination survey</article-title>. <source>BMC Geriatr</source>. (<year>2023</year>) <volume>23</volume>:<fpage>745</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12877-023-04438-4</pub-id></citation></ref>
<ref id="ref6"><label>6.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fried</surname> <given-names>LP</given-names></name> <name><surname>Tangen</surname> <given-names>CM</given-names></name> <name><surname>Walston</surname> <given-names>J</given-names></name> <name><surname>Newman</surname> <given-names>AB</given-names></name> <name><surname>Hirsch</surname> <given-names>C</given-names></name> <name><surname>Gottdiener</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Frailty in older adults: evidence for a phenotype</article-title>. <source>J Gerontol A Biol Sci Med Sci</source>. (<year>2001</year>) <volume>56</volume>:<fpage>M146</fpage>&#x2013;<lpage>56</lpage>. doi: <pub-id pub-id-type="doi">10.1093/gerona/56.3.M146</pub-id>, PMID: <pub-id pub-id-type="pmid">11253156</pub-id></citation></ref>
<ref id="ref7"><label>7.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bilgin</surname> <given-names>S</given-names></name> <name><surname>Aktas</surname> <given-names>G</given-names></name> <name><surname>Kahveci</surname> <given-names>G</given-names></name> <name><surname>Tel</surname> <given-names>A</given-names></name> <name><surname>Kurtkulagi</surname> <given-names>O</given-names></name> <name><surname>Taslamacioglu</surname> <given-names>DT</given-names></name></person-group>. <article-title>Does mean platelet volume/lymphocyte count ratio associate with frailty in type 2 diabetes mellitus?</article-title> <source>Bratisl Lek Listy</source>. (<year>2021</year>) <volume>122</volume>:116&#x2013;119. doi: <pub-id pub-id-type="doi">10.4149/BLL_2021_017</pub-id>, PMID: <pub-id pub-id-type="pmid">33502879</pub-id></citation></ref>
<ref id="ref8"><label>8.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taslamacioglu Duman</surname> <given-names>T</given-names></name> <name><surname>Ozkul</surname> <given-names>FN</given-names></name> <name><surname>Balci</surname> <given-names>B</given-names></name></person-group>. <article-title>Could systemic inflammatory index predict diabetic kidney injury in type 2 diabetes mellitus?</article-title> <source>Diagnostics</source>. (<year>2023</year>) <volume>13</volume>:<fpage>2063</fpage>. doi: <pub-id pub-id-type="doi">10.3390/diagnostics13122063</pub-id>, PMID: <pub-id pub-id-type="pmid">37370958</pub-id></citation></ref>
<ref id="ref9"><label>9.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dziedzic</surname> <given-names>EA</given-names></name> <name><surname>G&#x0105;sior</surname> <given-names>JS</given-names></name> <name><surname>Tuzimek</surname> <given-names>A</given-names></name> <name><surname>Paleczny</surname> <given-names>J</given-names></name> <name><surname>Junka</surname> <given-names>A</given-names></name> <name><surname>D&#x0105;browski</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Investigation of the associations of novel inflammatory biomarkers&#x2014;systemic inflammatory index (SII) and systemic inflammatory response index (SIRI)&#x2014;with the severity of coronary artery disease and acute coronary syndrome occurrence</article-title>. <source>Int J Mol Sci</source>. (<year>2022</year>) <volume>23</volume>:<fpage>9553</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms23179553</pub-id>, PMID: <pub-id pub-id-type="pmid">36076952</pub-id></citation></ref>
<ref id="ref10"><label>10.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mahemuti</surname> <given-names>N</given-names></name> <name><surname>Jing</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>N</given-names></name> <name><surname>Liu</surname> <given-names>C</given-names></name> <name><surname>Li</surname> <given-names>C</given-names></name> <name><surname>Cui</surname> <given-names>Z</given-names></name> <etal/></person-group>. <article-title>Association between systemic immunity-inflammation index and hyperlipidemia: a population-based study from the NHANES (2015-2020)</article-title>. <source>Nutrients</source>. (<year>2023</year>) <volume>15</volume>:<fpage>1177</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu15051177</pub-id>, PMID: <pub-id pub-id-type="pmid">36904176</pub-id></citation></ref>
<ref id="ref11"><label>11.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Soest</surname> <given-names>RJ</given-names></name> <name><surname>Templeton</surname> <given-names>AJ</given-names></name> <name><surname>Vera-Badillo</surname> <given-names>FE</given-names></name> <name><surname>Mercier</surname> <given-names>F</given-names></name> <name><surname>Sonpavde</surname> <given-names>G</given-names></name> <name><surname>Amir</surname> <given-names>E</given-names></name> <etal/></person-group>. <article-title>Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials</article-title>. <source>Ann Oncol</source>. (<year>2015</year>) <volume>26</volume>:<fpage>743</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1093/annonc/mdu569</pub-id>, PMID: <pub-id pub-id-type="pmid">25515657</pub-id></citation></ref>
<ref id="ref12"><label>12.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname> <given-names>YS</given-names></name> <name><surname>Tan</surname> <given-names>J</given-names></name> <name><surname>Zhou</surname> <given-names>XL</given-names></name> <name><surname>Song</surname> <given-names>YQ</given-names></name> <name><surname>Song</surname> <given-names>YJ</given-names></name></person-group>. <article-title>Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer</article-title>. <source>J Transl Med</source>. (<year>2017</year>) <volume>15</volume>:<fpage>221</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12967-017-1326-1</pub-id></citation></ref>
<ref id="ref13"><label>13.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname> <given-names>W</given-names></name> <name><surname>Fang</surname> <given-names>Y</given-names></name> <name><surname>Zhou</surname> <given-names>B</given-names></name> <name><surname>Mao</surname> <given-names>G</given-names></name> <name><surname>Cheng</surname> <given-names>J</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name> <etal/></person-group>. <article-title>The association of systemic inflammatory biomarkers with non-alcoholic fatty liver disease: a large population-based cross-sectional study</article-title>. <source>Prev Med Rep</source>. (<year>2024</year>) <volume>37</volume>:<fpage>102536</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pmedr.2023.102536</pub-id>, PMID: <pub-id pub-id-type="pmid">38186662</pub-id></citation></ref>
<ref id="ref14"><label>14.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname> <given-names>N</given-names></name> <name><surname>Huang</surname> <given-names>L</given-names></name> <name><surname>Hong</surname> <given-names>J</given-names></name> <name><surname>Zhao</surname> <given-names>X</given-names></name> <name><surname>Hu</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>S</given-names></name> <etal/></person-group>. <article-title>The association between systemic inflammation markers and the prevalence of hypertension</article-title>. <source>BMC Cardiovasc Disord</source>. (<year>2023</year>) <volume>23</volume>:<fpage>615</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12872-023-03661-6</pub-id></citation></ref>
<ref id="ref15"><label>15.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dziedzic</surname> <given-names>EA</given-names></name> <name><surname>G&#x0105;sior</surname> <given-names>JS</given-names></name> <name><surname>Tuzimek</surname> <given-names>A</given-names></name> <name><surname>D&#x0105;browski</surname> <given-names>M</given-names></name> <name><surname>Jankowski</surname> <given-names>P</given-names></name></person-group>. <article-title>The association between serum vitamin D concentration and new inflammatory biomarkers-systemic inflammatory index (SII) and systemic inflammatory response (SIRI)-in patients with ischemic heart disease</article-title>. <source>Nutrients</source>. (<year>2022</year>) <volume>14</volume>:<fpage>4212</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu14194212</pub-id>, PMID: <pub-id pub-id-type="pmid">36235864</pub-id></citation></ref>
<ref id="ref16"><label>16.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soysal</surname> <given-names>P</given-names></name> <name><surname>Stubbs</surname> <given-names>B</given-names></name> <name><surname>Lucato</surname> <given-names>P</given-names></name> <name><surname>Luchini</surname> <given-names>C</given-names></name> <name><surname>Solmi</surname> <given-names>M</given-names></name> <name><surname>Peluso</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Inflammation and frailty in the elderly: a systematic review and meta-analysis</article-title>. <source>Ageing Res Rev</source>. (<year>2016</year>) <volume>31</volume>:<fpage>1</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.arr.2016.08.006</pub-id>, PMID: <pub-id pub-id-type="pmid">27592340</pub-id></citation></ref>
<ref id="ref17"><label>17.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H</given-names></name> <name><surname>Hao</surname> <given-names>M</given-names></name> <name><surname>Hu</surname> <given-names>Z</given-names></name> <name><surname>Li</surname> <given-names>Y</given-names></name> <name><surname>Jiang</surname> <given-names>X</given-names></name> <name><surname>Wang</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Association of immunity markers with the risk of incident frailty: the Rugao longitudinal aging study</article-title>. <source>Immun Ageing</source>. (<year>2022</year>) <volume>19</volume>:<fpage>1</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12979-021-00257-6</pub-id></citation></ref>
<ref id="ref18"><label>18.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>J</given-names></name> <name><surname>Wang</surname> <given-names>T</given-names></name> <name><surname>Li</surname> <given-names>H</given-names></name> <name><surname>Yin</surname> <given-names>C</given-names></name> <name><surname>Liu</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Moderate selenium mitigates hand grip strength impairment associated with elevated blood cadmium and lead levels in middle-aged and elderly individuals: insights from NHANES 2011-2014</article-title>. <source>Front Pharmacol</source>. (<year>2023</year>) <volume>14</volume>:<fpage>1324583</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2023.1324583</pub-id></citation></ref>
<ref id="ref19"><label>19.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname> <given-names>Y</given-names></name> <name><surname>Yin</surname> <given-names>L</given-names></name> <name><surname>Yin</surname> <given-names>X</given-names></name> <name><surname>Zhao</surname> <given-names>D</given-names></name></person-group>. <article-title>Total cholesterol mediates the association between history of gestational diabetes mellitus and bone mineral density in US women aged 20-49 years</article-title>. <source>BMC Public Health</source>. (<year>2024</year>) <volume>24</volume>:<fpage>81</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12889-023-17609-0</pub-id></citation></ref>
<ref id="ref20"><label>20.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname> <given-names>YS</given-names></name> <name><surname>Cao</surname> <given-names>F</given-names></name> <name><surname>Musonye</surname> <given-names>HA</given-names></name> <name><surname>Xu</surname> <given-names>YQ</given-names></name> <name><surname>Gao</surname> <given-names>ZX</given-names></name> <name><surname>Ge</surname> <given-names>M</given-names></name> <etal/></person-group>. <article-title>Serum albumin mediates the associations between heavy metals and two novel systemic inflammation indexes among U.S. adults</article-title>. <source>Ecotoxicol Environ Saf</source>. (<year>2024</year>) <volume>270</volume>:<fpage>115863</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ecoenv.2023.115863</pub-id>, PMID: <pub-id pub-id-type="pmid">38134642</pub-id></citation></ref>
<ref id="ref21"><label>21.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>L</given-names></name></person-group>. <article-title>Association of energy-adjusted dietary inflammatory index and frailty in older adults with nonalcoholic fatty liver disease</article-title>. <source>Exp Gerontol</source>. (<year>2023</year>) <volume>182</volume>:<fpage>112296</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.exger.2023.112296</pub-id>, PMID: <pub-id pub-id-type="pmid">37734669</pub-id></citation></ref>
<ref id="ref22"><label>22.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Searle</surname> <given-names>SD</given-names></name> <name><surname>Mitnitski</surname> <given-names>A</given-names></name> <name><surname>Gahbauer</surname> <given-names>EA</given-names></name> <name><surname>Gill</surname> <given-names>TM</given-names></name> <name><surname>Rockwood</surname> <given-names>K</given-names></name></person-group>. <article-title>A standard procedure for creating a frailty index</article-title>. <source>BMC Geriatr</source>. (<year>2008</year>) <volume>8</volume>:<fpage>24</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2318-8-24</pub-id></citation></ref>
<ref id="ref23"><label>23.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferrucci</surname> <given-names>L</given-names></name> <name><surname>Guralnik</surname> <given-names>JM</given-names></name> <name><surname>Studenski</surname> <given-names>S</given-names></name> <name><surname>Fried</surname> <given-names>LP</given-names></name> <name><surname>Cutler</surname> <given-names>GB</given-names> <suffix>Jr</suffix></name> <name><surname>Walston</surname> <given-names>JD</given-names></name></person-group>. <article-title>Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report</article-title>. <source>J Am Geriatr Soc</source>. (<year>2004</year>) <volume>52</volume>:<fpage>625</fpage>&#x2013;<lpage>34</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1532-5415.2004.52174.x</pub-id>, PMID: <pub-id pub-id-type="pmid">15066083</pub-id></citation></ref>
<ref id="ref24"><label>24.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joo</surname> <given-names>SH</given-names></name> <name><surname>Song</surname> <given-names>JW</given-names></name> <name><surname>Shin</surname> <given-names>K</given-names></name> <name><surname>Kim</surname> <given-names>MJ</given-names></name> <name><surname>Lee</surname> <given-names>J</given-names></name> <name><surname>Song</surname> <given-names>YW</given-names></name></person-group>. <article-title>Knee osteoarthritis with a high grade of Kellgren-Lawrence score is associated with a worse frailty status, KNHANES 2010-2013</article-title>. <source>Sci Rep</source>. (<year>2023</year>) <volume>13</volume>:<fpage>19714</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-023-46558-2</pub-id></citation></ref>
<ref id="ref25"><label>25.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>J</given-names></name> <name><surname>Zhou</surname> <given-names>D</given-names></name> <name><surname>Dai</surname> <given-names>Z</given-names></name> <name><surname>Li</surname> <given-names>X</given-names></name></person-group>. <article-title>Association between systemic immune-inflammation index and diabetic depression</article-title>. <source>Clin Interv Aging</source>. (<year>2021</year>) 16:<fpage>97</fpage>&#x2013;<lpage>105</lpage>. doi: <pub-id pub-id-type="doi">10.2147/CIA.S285000</pub-id>, PMID: <pub-id pub-id-type="pmid">33469277</pub-id></citation></ref>
<ref id="ref26"><label>26.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ar&#x0131;</surname> <given-names>E</given-names></name> <name><surname>K&#x00F6;seo&#x011F;lu</surname> <given-names>H</given-names></name> <name><surname>Ero&#x011F;lu</surname> <given-names>T</given-names></name></person-group>. <article-title>Predictive value of SIRI and SII for metastases in RCC: a prospective clinical study</article-title>. <source>BMC Urol</source>. (<year>2024</year>) <volume>24</volume>:<fpage>14</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12894-024-01401-2</pub-id></citation></ref>
<ref id="ref27"><label>27.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname> <given-names>A</given-names></name> <name><surname>Zhang</surname> <given-names>B</given-names></name> <name><surname>Wang</surname> <given-names>S</given-names></name> <name><surname>Feng</surname> <given-names>Y</given-names></name> <name><surname>Liu</surname> <given-names>S</given-names></name> <name><surname>Liu</surname> <given-names>C</given-names></name> <etal/></person-group>. <article-title>Comparison of the value of various complex indexes of blood cell types and lipid levels in coronary heart disease</article-title>. <source>Front Cardiovas Med</source>. (<year>2023</year>) <volume>10</volume>:<fpage>1284491</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcvm.2023.1284491</pub-id></citation></ref>
<ref id="ref28"><label>28.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>M</given-names></name> <name><surname>Miao</surname> <given-names>S</given-names></name> <name><surname>Hu</surname> <given-names>W</given-names></name> <name><surname>Yan</surname> <given-names>J</given-names></name></person-group>. <article-title>Association between the dietary inflammatory index and all-cause and cardiovascular mortality in patients with atherosclerotic cardiovascular disease</article-title>. <source>Nutr Metab Cardiovasc Dis</source>. (<year>2024</year>) <volume>34</volume>:<fpage>1046</fpage>&#x2013;<lpage>53</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.numecd.2023.11.015</pub-id></citation></ref>
<ref id="ref29"><label>29.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meshkat</surname> <given-names>S</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Jung</surname> <given-names>H</given-names></name> <name><surname>Tassone</surname> <given-names>VK</given-names></name> <name><surname>Pang</surname> <given-names>H</given-names></name> <name><surname>Janssen-Aguilar</surname> <given-names>R</given-names></name> <etal/></person-group>. <article-title>Temporal associations of BMI and glucose parameters with depressive symptoms among US adults</article-title>. <source>Psychiatry Res</source>. (<year>2024</year>) <volume>332</volume>:<fpage>115709</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.psychres.2023.115709</pub-id>, PMID: <pub-id pub-id-type="pmid">38211470</pub-id></citation></ref>
<ref id="ref30"><label>30.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>J</given-names></name> <name><surname>Xu</surname> <given-names>ZX</given-names></name> <name><surname>Yang</surname> <given-names>QF</given-names></name> <name><surname>Zhuang</surname> <given-names>J</given-names></name> <name><surname>Zhu</surname> <given-names>X</given-names></name> <name><surname>Yao</surname> <given-names>J</given-names></name></person-group>. <article-title>Association between the sarcopenia index and abnormal liver function in the adult population in the United States: a cross-sectional study</article-title>. <source>Front Med</source>. (<year>2023</year>) <volume>10</volume>:<fpage>1266253</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmed.2023.1266253</pub-id></citation></ref>
<ref id="ref31"><label>31.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baniak</surname> <given-names>LM</given-names></name> <name><surname>Yang</surname> <given-names>K</given-names></name> <name><surname>Choi</surname> <given-names>J</given-names></name> <name><surname>Chasens</surname> <given-names>ER</given-names></name></person-group>. <article-title>Long sleep duration is associated with increased frailty risk in older community-dwelling adults</article-title>. <source>J Aging Health</source>. (<year>2020</year>) <volume>32</volume>:<fpage>42</fpage>&#x2013;<lpage>51</lpage>. doi: <pub-id pub-id-type="doi">10.1177/0898264318803470</pub-id>, PMID: <pub-id pub-id-type="pmid">30270714</pub-id></citation></ref>
<ref id="ref32"><label>32.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jayanama</surname> <given-names>K</given-names></name> <name><surname>Theou</surname> <given-names>O</given-names></name> <name><surname>Blodgett</surname> <given-names>JM</given-names></name> <name><surname>Cahill</surname> <given-names>L</given-names></name> <name><surname>Rockwood</surname> <given-names>K</given-names></name></person-group>. <article-title>Frailty, nutrition-related parameters, and mortality across the adult age spectrum</article-title>. <source>BMC Med</source>. (<year>2018</year>) <volume>16</volume>:<fpage>1</fpage>&#x2013;<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1186/s12916-018-1176-6</pub-id></citation></ref>
<ref id="ref33"><label>33.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrera</surname> <given-names>A</given-names></name> <name><surname>Rezende</surname> <given-names>LFM</given-names></name> <name><surname>Sabag</surname> <given-names>A</given-names></name> <name><surname>Keating</surname> <given-names>CJ</given-names></name> <name><surname>Rey-Lopez</surname> <given-names>JP</given-names></name></person-group>. <article-title>Understanding the causes of frailty using a life-course perspective: a systematic review</article-title>. <source>Healthcare (Basel, Switzerland)</source>. (<year>2023</year>) <volume>12</volume>:<fpage>22</fpage>. doi: <pub-id pub-id-type="doi">10.3390/healthcare12010022</pub-id></citation></ref>
<ref id="ref34"><label>34.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Udell</surname> <given-names>JA</given-names></name> <name><surname>Lu</surname> <given-names>D</given-names></name> <name><surname>Bagai</surname> <given-names>A</given-names></name> <name><surname>Dodson</surname> <given-names>JA</given-names></name> <name><surname>Desai</surname> <given-names>NR</given-names></name> <name><surname>Fonarow</surname> <given-names>GC</given-names></name> <etal/></person-group>. <article-title>Preexisting frailty and outcomes in older patients with acute myocardial infarction</article-title>. <source>Am Heart J</source>. (<year>2022</year>) <volume>249</volume>:<fpage>34</fpage>&#x2013;<lpage>44</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ahj.2022.03.007</pub-id>, PMID: <pub-id pub-id-type="pmid">35339451</pub-id></citation></ref>
<ref id="ref35"><label>35.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zong</surname> <given-names>M</given-names></name> <name><surname>Guan</surname> <given-names>X</given-names></name> <name><surname>Huang</surname> <given-names>W</given-names></name> <name><surname>Chang</surname> <given-names>J</given-names></name> <name><surname>Zhang</surname> <given-names>J</given-names></name></person-group>. <article-title>Effect of frailty on the long-term prognosis of elderly patients with acute myocardial infarction</article-title>. <source>Clin Interv Aging</source>. (<year>2023</year>) <volume>18</volume>:<fpage>2021</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.2147/CIA.S433221</pub-id></citation></ref>
<ref id="ref36"><label>36.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamaguchi</surname> <given-names>K</given-names></name> <name><surname>Miyagami</surname> <given-names>T</given-names></name> <name><surname>Imada</surname> <given-names>R</given-names></name> <name><surname>Kushiro</surname> <given-names>S</given-names></name> <name><surname>Yanagida</surname> <given-names>R</given-names></name> <name><surname>Morikawa</surname> <given-names>T</given-names></name> <etal/></person-group>. <article-title>Effect of poor oral health status at hospital admission on in-hospital outcomes of older patients with aspiration pneumonia</article-title>. <source>Eur Geriatr Med</source>. (<year>2024</year>) <fpage>1</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s41999-023-00917-4</pub-id>, PMID: <pub-id pub-id-type="pmid">38214864</pub-id></citation></ref>
<ref id="ref37"><label>37.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname> <given-names>Y</given-names></name> <name><surname>Ma</surname> <given-names>L</given-names></name></person-group>. <article-title>Inflammatory markers and physical frailty: towards clinical application</article-title>. <source>Immun Ageing</source>. (<year>2024</year>) <volume>21</volume>:<fpage>4</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12979-023-00410-3</pub-id></citation></ref>
<ref id="ref38"><label>38.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>L</given-names></name> <name><surname>Zeng</surname> <given-names>X</given-names></name> <name><surname>He</surname> <given-names>F</given-names></name> <name><surname>Huang</surname> <given-names>X</given-names></name></person-group>. <article-title>Inflammatory biomarkers of frailty: a review</article-title>. <source>Exp Gerontol</source>. (<year>2023</year>) <volume>179</volume>:<fpage>112253</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.exger.2023.112253</pub-id>, PMID: <pub-id pub-id-type="pmid">37429425</pub-id></citation></ref>
<ref id="ref39"><label>39.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>M</given-names></name> <name><surname>Chen</surname> <given-names>D</given-names></name> <name><surname>Jiang</surname> <given-names>X</given-names></name> <name><surname>Xiong</surname> <given-names>Z</given-names></name></person-group>. <article-title>Inflammatory biomarkers in older adults with frailty: a systematic review and meta-analysis of cross-sectional studies</article-title>. <source>Aging Clin Exp Res</source>. (<year>2022</year>) <volume>34</volume>:<fpage>971</fpage>&#x2013;<lpage>87</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s40520-021-02022-7</pub-id>, PMID: <pub-id pub-id-type="pmid">34981430</pub-id></citation></ref>
<ref id="ref40"><label>40.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferrucci</surname> <given-names>L</given-names></name> <name><surname>Fabbri</surname> <given-names>E</given-names></name></person-group>. <article-title>Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty</article-title>. <source>Nat Rev Cardiol</source>. (<year>2018</year>) <volume>15</volume>:<fpage>505</fpage>&#x2013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41569-018-0064-2</pub-id>, PMID: <pub-id pub-id-type="pmid">30065258</pub-id></citation></ref>
<ref id="ref41"><label>41.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>van Sleen</surname> <given-names>Y</given-names></name> <name><surname>Shetty</surname> <given-names>SA</given-names></name> <name><surname>van der Heiden</surname> <given-names>M</given-names></name> <name><surname>Venema</surname> <given-names>MCA</given-names></name> <name><surname>Guti&#x00E9;rrez-Melo</surname> <given-names>N</given-names></name> <name><surname>Toonen</surname> <given-names>EJM</given-names></name> <etal/></person-group>. <article-title>Frailty is related to serum inflammageing markers: results from the VITAL study</article-title>. <source>Immun Ageing</source>. (<year>2023</year>) <volume>20</volume>:<fpage>68</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12979-023-00391-3</pub-id></citation></ref>
<ref id="ref42"><label>42.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonilla</surname> <given-names>FA</given-names></name> <name><surname>Oettgen</surname> <given-names>HC</given-names></name></person-group>. <article-title>Adaptive immunity</article-title>. <source>J Allergy Clin Immunol</source>. (<year>2010</year>) <volume>125</volume>:<fpage>S33</fpage>&#x2013;<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jaci.2009.09.017</pub-id>, PMID: <pub-id pub-id-type="pmid">20061006</pub-id></citation></ref>
<ref id="ref43"><label>43.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fest</surname> <given-names>J</given-names></name> <name><surname>Ruiter</surname> <given-names>TR</given-names></name> <name><surname>Groot Koerkamp</surname> <given-names>B</given-names></name> <name><surname>Rizopoulos</surname> <given-names>D</given-names></name> <name><surname>Ikram</surname> <given-names>MA</given-names></name> <name><surname>van Eijck</surname> <given-names>CHJ</given-names></name> <etal/></person-group>. <article-title>The neutrophil-to-lymphocyte ratio is associated with mortality in the general population: the Rotterdam study</article-title>. <source>Eur J Epidemiol</source>. (<year>2019</year>) <volume>34</volume>:<fpage>463</fpage>&#x2013;<lpage>70</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10654-018-0472-y</pub-id>, PMID: <pub-id pub-id-type="pmid">30569368</pub-id></citation></ref>
<ref id="ref44"><label>44.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>W</given-names></name> <name><surname>Wei</surname> <given-names>C</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Sun</surname> <given-names>Q</given-names></name> <name><surname>Tian</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>X</given-names></name> <etal/></person-group>. <article-title>The prognostic value of hematologic inflammatory markers in patients with acute coronary syndrome undergoing percutaneous coronary intervention</article-title>. <source>Clin Appl Thromb Hemost</source>. (<year>2022</year>) <volume>28</volume>:<fpage>10760296221146183</fpage>. doi: <pub-id pub-id-type="doi">10.1177/10760296221146183</pub-id>, PMID: <pub-id pub-id-type="pmid">36567485</pub-id></citation></ref>
<ref id="ref45"><label>45.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname> <given-names>X</given-names></name> <name><surname>Liu</surname> <given-names>Y</given-names></name> <name><surname>Tian</surname> <given-names>Y</given-names></name> <name><surname>Rao</surname> <given-names>C</given-names></name> <name><surname>Shi</surname> <given-names>F</given-names></name> <name><surname>Bu</surname> <given-names>H</given-names></name> <etal/></person-group>. <article-title>Prognostic value of peripheral blood inflammatory cell subsets in patients with acute coronary syndrome undergoing percutaneous coronary intervention</article-title>. <source>J Int Med Res</source>. (<year>2021</year>) <volume>49</volume>:<fpage>3000605211010059</fpage>. doi: <pub-id pub-id-type="doi">10.1177/03000605211010059</pub-id>, PMID: <pub-id pub-id-type="pmid">33900867</pub-id></citation></ref>
<ref id="ref46"><label>46.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname> <given-names>S</given-names></name> <name><surname>Dong</surname> <given-names>S</given-names></name> <name><surname>Qin</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>Y</given-names></name> <name><surname>Zhang</surname> <given-names>B</given-names></name> <name><surname>Liu</surname> <given-names>A</given-names></name></person-group>. <article-title>Inflammation index SIRI is associated with increased all-cause and cardiovascular mortality among patients with hypertension</article-title>. <source>Front Cardiovas Med</source>. (<year>2022</year>) <volume>9</volume>:<fpage>1066219</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fcvm.2022.1066219</pub-id>, PMID: <pub-id pub-id-type="pmid">36712259</pub-id></citation></ref>
<ref id="ref47"><label>47.</label> <citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zipf</surname> <given-names>G</given-names></name> <name><surname>Chiappa</surname> <given-names>M</given-names></name> <name><surname>Porter</surname> <given-names>KS</given-names></name> <name><surname>Ostchega</surname> <given-names>Y</given-names></name> <name><surname>Lewis</surname> <given-names>BG</given-names></name> <name><surname>Dostal</surname> <given-names>J</given-names></name></person-group>. <article-title>National health and nutrition examination survey: plan and operations, 1999-2010</article-title>. <source>Vital Health Stat 1</source>. (<year>2013</year>):<fpage>1</fpage>&#x2013;<lpage>37</lpage>. PMID: <pub-id pub-id-type="pmid">25078429</pub-id></citation></ref>
</ref-list>
</back>
</article>